BioTechniques Online Event: Advancing Precision Medicine 2019
Over the last decade, precision medicine has taken leaps forward, with projects such as the Precision Medicine Initiative, All of Us and the Human Cancer Models Initiative putting a huge impetus behind the development of new technologies to improve the diagnosis and treatment of human disease.
Our BioTechniques Online Event: Advancing Precision Medicine 2019, is a free, 2-day virtual symposium that will provide an overview of the latest technical advances in this field and explore how they are being harnessed to translate research from the bench to the bedside.
To secure your free ticket now Register Here
What is a virtual symposium?
Our virtual symposium will be very similar to conferences that you have been to before, except that you can attend it online from the comfort of your own home, lab or office.
There will be presentations, panel discussions, workshops, exhibition and networking areas – all the benefits of a regular conference – without the negatives: no travel, no expensive hotels, no disruption to your regular working week and what’s more, it’s free to attend!
The added bonus of this online event is if you can’t make it on the live dates you do not have to miss out. All talks, workshops and materials will be available on demand after the event to everyone that has registered.
Sessions and speakers
Join us for the following sessions:
- Hidden in the Genome: the application of techniques such as NGS and CRISPR for precision medicine
- Cells as Models: cell biology techniques for modeling diseases such as cancer and neurodegeneration, and for targeting drug discovery
- Host–Pathogen/Environment Interactions: how concepts such as sequencing and bioinformatics can be used to harness lifestyle and the microbiome for diagnostics and prediction
- Moving Toward the Clinic: the techniques involved in moving precision therapeutics from the bench to the bedside
How can I attend?
Registering for this event is easy! All you need to do is click on this link, complete the short form and wait for your email invite. We will send you an email as soon as the event is open so you can go in and personalize your agenda, so you don’t miss out on sessions that interest you.
Emails will be sent on the day to let you know it’s started and then you can join us online, learn and ask questions to experts and network with colleagues.
What to expect from the event
- Mini panel discussions within the four key sessions
- Interactive breakout sessions in hot-topic areas, such as CRISPR, infectious diseases, 3D printing and more!
- Educational workshops covering lab best practice
- Q&A sessions with experts
- Exhibitor booths with networking opportunities
- Downloadable materials for you to review at your own leisure
Dr. Stephanie Devaney – Plenary speaker
Stephanie Devaney is the Deputy Director of the All of Us Research Program at the National Institutes of Health (MD, USA). Prior to this, she led the coordination of the Precision Medicine Initiative from the Office of the Chief of Staff at the White House (DC, USA). In this role, she coordinated the many components of the initiative and guided the vision of the overall effort, along with the many federal partners. Before joining the White House, Stephanie worked in the Office of the Director at the National Institutes of Health. There she helped advance policies critical to biomedical research and the NIH mission and assisted in the development of programs and research initiatives to advance national scientific priorities, including the Precision Medicine Initiative. Prior to that, Stephanie was a researcher at the Genetics and Public Policy Center at Johns Hopkins University (MD, USA). There she conducted research on pharmacogenetics and drug labeling; performed a meta-analysis of non-invasive fetal gender genetic testing; and was involved in public engagement surrounding the many ethical and social issues that are emerging with novel genomic technologies. Stephanie received her Ph.D. in Molecular Genetics from the George Washington University (DC, USA) and her B.S. in Biology from The Ohio State University (OH, USA).
Prof. Elaine Mardis – Hidden in the Genome session
Dr. Mardis is the Co-Executive Director of the Institute for Genomic Medicine and a Professor of Pediatrics at Nationwide Children’s Hospital (both OH, USA). Her research interests focus on the application of next-generation sequencing to characterize cancer genomes and transcriptomes, and to support therapeutic decision-making. Her translational research efforts devise sequencing-based diagnostics, decision-support tools and databases, and the use of genomics to design personalized cancer vaccines. Dr. Mardis was on the faculty at Washington University School of Medicine (MO, USA) from 1993-2016, where she became co-director of the McDonnell Genome Institute in 2002 and was named the Robert E. and Louise F. Dunn distinguished professor of medicine in 2014. Previously, she was a senior research scientist at BioRad Laboratories (CA, USA). Dr. Mardis graduated from the University of Oklahoma (OK, USA) with a BS in zoology and completed her Ph.D. in chemistry and biochemistry, also at Oklahoma.
Prof. Rob Knight – Host-Pathogen/Environment session
Rob Knight is the founding Director of the Center for Microbiome Innovation and Professor of Pediatrics and Computer Science & Engineering at UC San Diego (CA, USA). Before that, he was Professor of Chemistry & Biochemistry and Computer Science in the BioFrontiers Institute of the University of Colorado at Boulder (CO, USA), and a Howard Hughs Medical Institute Early Career Scientist (MD, USA). He is a fellow of the American Association for the Advancement of Science and of the American Academy of Microbiology (both DC, USA). He received the 2017 Massry Prize for his microbiome research. In 2015 he received the Vilceck Prize in Creative Promise for the Life Sciences. He is the author of “Follow your gut: the enormous impact of tiny microbes” (Simon & Schuster, 2015), coauthor of “Dirt is good: the advantage of germs for your child’s developing immune system (St. Martin’s Press, 2017) and spoke at TED in 2014. His lab has produced many of the software tools and laboratory techniques that enabled high-throughput microbiome science, including the QIIME pipeline (cited over 10,000 times as of this writing) and UniFrac (cited over 5000 times including its web interface). He is the co-founder of the Earth Microbiome Project, the American Gut Project, and the company Biota, Inc. (CA, USA), which uses DNA from microbes in the subsurface to guide oilfield decisions. His work has linked microbes to a range of health conditions including obesity and inflammatory bowel disease, has enhanced our understanding of microbes in environments ranging from the oceans to the tundra, and made high-throughput sequencing techniques accessible to thousands of researchers around the world.
Prof. Heidi Rehm – Moving Toward the Clinic session
Heidi Rehm is the Medical Director of the Clinical Research Sequencing Platform, a human geneticist and genomic medicine researcher and an institute member at the Broad Institute (MA, USA). She is the Chief Genomics Officer in the Department of Medicine at Massachusetts General Hospital (MGH; MA, USA). She is also a professor of pathology at MGH, Brigham and Women’s Hospital (BWH) and Harvard Medical School. She is a board-certified geneticist and leader in defining standards for the interpretation of sequence variants and a principal investigator of a major NIH-funded effort called ClinGen (Clinical Genome Resource), providing free and publicly accessible resources to support the interpretation of genes and variants.
Rehm also co-leads the Broad Center for Mendelian Genomics with Daniel MacArthur focused on discovering novel rare disease genes and co-leads the Matchmaker Exchange to aid in gene discovery. She is a strong advocate and pioneer of open science and data sharing, working to extend these approaches through her role on the steering committee of the Global Alliance for Genomics and Health. Rehm is also a co-investigator of the BabySeq Project exploring the clinical use of genomic sequencing as an adjunct to newborn screening; principal investigator in the eMERGE consortium supporting genomic discovery and genomic medicine implementation; and a principal investigator on a project to develop the Informatics for Integrating Biology and the Bedside (i2b2) center into a health innovation platform for clinical decision support.
David Tuveson – Cells as Models session
David Tuveson’s group is located at Cold Spring Harbour Laboratory (NY, USA) and the Lustgarten Foundation, where they use murine and human models of pancreatic cancer to explore the fundamental biology of malignancy and thereby identify new diagnostic and treatment strategies. The lab’s approaches run the gamut from designing new model systems of disease to developing new therapeutic and diagnostic approaches for rapid evaluation in preclinical and clinical settings. The lab’s studies make use of organoid cultures—three-dimensional cultures of normal or cancerous epithelia—as ex vivo models to probe cancer biology.
Partner with us today to ensure your company benefits not only during the live dates of the BioTechniques Online Event itself but also from promotional activities across our expansive social media channels and pre and post event activities.
Why should you be involved?
Be valued as an equal, contribute to all conversations and be fully immersed in this interactive event
Be part of the inaugural BioTechniques Online Event, ensuring your company is aligned to an event that is solution-focused and ultimately aims to benefit researchers, industry, clinicians, and patients alike
Benefit from our proven track record in delivering results and providing active leads
Make the most of your marketing budget by reaching our audience before, during and post event
Help shape the future of not only this event, but the future of precision medicine
Exhibitors will be able to connect & engage directly with BioTechniques’ international audience and showcase their products with videos, posters and workshops. 1500 – 2000 bench top scientists are expected to attend.
Exhibitors are eligible to receive the following and will benefit from promotional activities in the BioTechniques journal, online, focused emails and social media. Diamond, Gold, Silver and Bronze sponsorship levels are available and start at $6500.
For further details on sponsorship levels, please contact a member of the team.
If you would like to participate and be an event sponsor, you may contact: Carol Nettles at [email protected], +1 404.347.1755.
For more information on how to partner with us on this new event, contact Business Development Director, Sarah Mayes, via email at [email protected] or call +44(0)7456810407.
Full program to be announced soon. Sessions to include:
Plenary – Stephanie Devaney, All of Us
Track 1 – Hidden in the genome: from genotype to phenotype
Keynote: Elaine Mardis, co-executive director of the Institute for Genomic Medicine and a professor of pediatrics at Nationwide Children’s Hospital (both OH, USA)
Speaker 1: John Quackenbush, Harvard
Speaker 2: To be confirmed
Track 2 – From the inside out: host–pathogen & environment interactions
Keynote: Rob Knight, Center for Microbiome Innovation and Professor of Pediatrics and Computer Science & Engineering at UC San Diego
Speaker 1: Michael Snyder, Stanford University
Speaker 2: To be confirmed
Track 3 – Cells as models
Keynote: David Tuveson, Cold Spring Harbour
Speaker 1: Rob Vries- Hubrecht Organoid Technology
Speaker 2: To be confirmed
This track is kindly supported by ATCC.
Track 4 – Translational research: moving toward the clinic
Keynote: Heidi Rehm, Clinical Research Sequencing Platform, Broad Institute
Speaker 1: Marni Falk, Children’s Hospital of Philadelphia
Speaker 2: George Patrinos, University of Patras